Quinaprilat

This classification denotes an ace inhibitor with the molecular formula C23H26N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 34SSX5LDE5, chemically known as 3-isoquinolinecarboxylic acid, 2-((2s)-2-(((1s)-1-carboxy-3-phenylpropyl)amino)-1-oxopropyl)-1,2,3,4-tetrahydro-, (3s)- but generally known as quinaprilat, which bears US NIH Compound Identifier 107994. European Medicines Agency schedules Quinaprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10202MIG. The term QUINAPRILAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). QUINAPRILAT is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quinaprilat under HS 29334990 and SITC 51575. As of Q4 2014, QUINAPRILAT remains the US FDA Preferred Term for this commodity. Quinaprilat bears US NLM identifiers UMLS ID C0072858 and NCI Concept Code C95129. SMILES: O=C(N1C(Cc2c(C1)cccc2)C(=O)O)C(NC(CCc1ccccc1)C(=O)O)C.